JNGLX
Price
$68.02
Change
+$0.16 (+0.24%)
Updated
Dec 20 closing price
LYFCX
Price
$12.31
Change
+$0.03 (+0.24%)
Updated
Dec 20 closing price
Ad is loading...

JNGLX vs LYFCX

Header iconJNGLX vs LYFCX Comparison
Open Charts JNGLX vs LYFCXBanner chart's image
Janus Henderson Global Life Sciences D
Price$68.02
Change+$0.16 (+0.24%)
VolumeN/A
CapitalizationN/A
AlphaCentric Life Sciences & Hlthcare C
Price$12.31
Change+$0.03 (+0.24%)
VolumeN/A
CapitalizationN/A
JNGLX vs LYFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LYFCX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and LYFCX is a StrongSell.

FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5.25B vs. LYFCX (53.2M). JNGLX pays higher dividends than LYFCX: JNGLX (0.12) vs LYFCX (0.00). JNGLX was incepted earlier than LYFCX: JNGLX (26 years) vs LYFCX (5 years). LYFCX is a more actively managed with annual turnover of: 142.00 vs. JNGLX (34.00). JNGLX (2500) and LYFCX (2500) have matching initial minimum investment requirements. LYFCX annual gain was more profitable for investors over the last year : 2.60 vs. JNGLX (1.49). LYFCX return over 5 years is better than : 21.56 vs. JNGLX (14.32).
JNGLXLYFCXJNGLX / LYFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years5 years-
Gain YTD-1.284-1.227105%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets5.25B53.2M9,874%
Annual Yield % from dividends0.120.00-
Returns for 1 year1.492.6057%
Returns for 3 years-0.01-5.000%
Returns for 5 years14.3221.5666%
Returns for 10 years37.06N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRMCX11.320.17
+1.52%
Voya Russell Mid Cap Index Port S
CSMEX26.730.37
+1.40%
Carillon Scout Mid Cap A
VWUAX188.271.76
+0.94%
Vanguard US Growth Admiral™
BRSBX14.100.12
+0.86%
MFS Blended Research Small Cap Eq B
LGCWX16.800.12
+0.72%
Lord Abbett Global Equity R6